Biotech

PeproMene Bio Reports Complete Remission in First Follicular Lymphoma Patient from Phase 1 Trial

BAFFR-targeted CAR T cell therapy shows promise in treating relapsed follicular lymphoma.

Using Jumping Genes for Safer, More Accurate DNA Editing

Researchers have developed a new gene-editing technique called bridge editing, which uses bacterial "jumping genes" to precisely insert large DNA sequences into the human genome without causing harmful DNA breaks, offering a safer and more efficient method for treating genetic disorders.

FDA Clears Blood Test for Diagnosing Alzheimer’s Disease

The FDA has approved a new plasma-based biomarker assay, the first blood-based diagnostic for Alzheimer's disease, offering a less invasive and more accessible alternative to traditional methods like PET scans and spinal taps.

Cerevance Reports Phase 2 Results for Solengepras in Early-Stage Parkinson’s Disease

Cerevance has announced topline results from its Phase 2 ASCEND trial of solengepras, showing a small but non-significant improvement in motor symptoms and potential benefits for non-motor symptoms, with a strong safety profile.

AstraZeneca to Acquire EsoBiotec in $1B Deal to Drive Next-Generation Cell Therapy

AstraZeneca announces acquisition of EsoBiotec for $1 billion, aiming to advance its cell therapy capabilities with EsoBiotec's in vivo genetic programming platform for cancer and immune-mediated diseases.

Magnetic Bead Separation: More Than Just a Magnet

We sit down with Sepmag's Lluís M. Martinez, Founder & CSO, and Josep-Maria Simó, Managing Director, to discuss the current state and future of magnetic separation technology.